Literature DB >> 27268142

Socioeconomic status and health outcomes: cystic fibrosis as a model.

Gabriela R Oates1, Michael S Schechter2.   

Abstract

INTRODUCTION: Socioeconomic status (SES), which indicates one's access to financial, educational, and social resources, is a powerful determinant of health outcomes in multiple chronic diseases. Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in a single gene. Although life expectancy and quality of life for patients with CF have improved exponentially, disease severity varies substantially, even among individuals with identical genotypes. AREAS COVERED: CF disease progression and outcomes are influenced by a number of nongenetic factors, such as material well-being, educational attainment, living and working conditions, physical environment and exposures, family environment, social support, health behaviors, and health care. This review discusses pathways by which financial, educational, and social resources are translated into health advantages in CF. Expert commentary: To achieve equitable CF outcomes, the contribution of nongenetic factors must be emphasized, highlighting the mechanisms through which the social and physical environments influence disease variability.

Entities:  

Keywords:  Cystic fibrosis; environmental exposures; health equality; health-care factors; respiratory outcomes; socioeconomic status

Mesh:

Year:  2016        PMID: 27268142     DOI: 10.1080/17476348.2016.1196140

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  19 in total

1.  Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis.

Authors:  Meghan E McGarry; John M Neuhaus; Dennis W Nielson; Esteban Burchard; Ngoc P Ly
Journal:  Pediatr Pulmonol       Date:  2017-10-30

2.  Associations between urinary biomarkers of oxidative stress in the third trimester of pregnancy and behavioral outcomes in the child at 4 years of age.

Authors:  Anna-Sophie Rommel; Ginger L Milne; Emily S Barrett; Nicole R Bush; Ruby Nguyen; Sheela Sathyanarayana; Shanna H Swan; Kelly K Ferguson
Journal:  Brain Behav Immun       Date:  2020-09-06       Impact factor: 7.217

3.  Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non-Hispanic subjects with cystic fibrosis in the United States.

Authors:  Meghan E McGarry; John M Neuhaus; Dennis W Nielson; Ngoc P Ly
Journal:  Pediatr Pulmonol       Date:  2019-05-29

Review 4.  Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies.

Authors:  Gabriela R Oates; Michael S Schechter
Journal:  Expert Rev Respir Med       Date:  2022-06-23       Impact factor: 4.300

5.  Family Socioeconomic Position and Lung Cancer Risk: A Meta-Analysis and a Mendelian Randomization Study.

Authors:  Xusen Zou; Runchen Wang; Zhao Yang; Qixia Wang; Wenhai Fu; Zhenyu Huo; Fan Ge; Ran Zhong; Yu Jiang; Jiangfu Li; Shan Xiong; Wen Hong; Wenhua Liang
Journal:  Front Public Health       Date:  2022-06-06

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

7.  The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.

Authors:  Gabriela Oates; Sarah Rutland; Lucia Juarez; Annabelle Friedman; Michael S Schechter
Journal:  Pediatr Pulmonol       Date:  2020-12-14

Review 8.  Left behind: The potential impact of CFTR modulators on racial and ethnic disparities in cystic fibrosis.

Authors:  Meghan E McGarry; Elizabeth R Gibb; Gabriela R Oates; Michael S Schechter
Journal:  Paediatr Respir Rev       Date:  2021-12-22       Impact factor: 5.526

Review 9.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

Review 10.  A new era for people with cystic fibrosis.

Authors:  Marlou C Bierlaagh; Danya Muilwijk; Jeffrey M Beekman; Cornelis K van der Ent
Journal:  Eur J Pediatr       Date:  2021-07-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.